Alva Review-Courier -

By Linda A. Johnson
AP Medical Writer 

FDA OKs Pfizer drug for rare, fast-killing type of leukemia

 

August 18, 2017



TRENTON, N.J. (AP) — The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed.

The agency approved Pfizer Inc.'s Besponsa for patients with a type of advanced acute lymphoblastic leukemia. By then, life expectancy is low.

"These patients have few treatments available and today's approval provides a new, targeted treatment option," Dr. Richard Pazdur, the FDA's director for cancer drugs, said in a statement.

This year an estimated 5,970 Americans will be diagnosed and 1,440 will die from the can...



For access to this article please sign in or subscribe.



 

Reader Comments(0)

 
 

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2020